Showing results (191-200 of 221) with videos related to
Sort By:
Pageof 23
American Journal of Obstetrics and Gynecology|February 12, 2017
Maternal buprenorphine treatment and fetal neurobehavioral developmentLauren M Jansson, Martha Velez, Krystle McConnell, et al.Journal of Human Lactation : Official Journal of International Lactation Consultant Association|August 27, 2016
Maternal Buprenorphine Maintenance and LactationLauren M Jansson, Nancy Spencer, Krystle McConnell, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|August 27, 2022
Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trialGary Peltz, Lauren M Jansson, Susan Adeniyi-Jones, et al.Trials|November 9, 2016
A core outcome set for neonatal abstinence syndrome: study protocol for a systematic review, parent interviews and a Delphi surveyLauren E Kelly, Lauren M Jansson, Wendy Moulsdale, et al.Genomics|February 13, 2001
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14B Kapanadze, N Makeeva, M Corcoran, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 5, 2013
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphineMargaret S Chisolm, Heather Fitzsimons, Jeannie-Marie S Leoutsakos, et al.Oncogene|May 12, 2015
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxisM-F Pang, A-M Georgoudaki, L Lambut, et al.Addictive Disorders & Their Treatment|July 27, 2012
Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant PatientsMargaret S Chisolm, Shauna P Acquavita, Karol Kaltenbach, et al.Drug and Alcohol Dependence|June 10, 2005
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndromeHendree E Jones, Rolley E Johnson, Donald R Jasinski, et al.Blood Cancer Journal|March 11, 2014
Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trialM Tobiasson, I Dybedahl, M S Holm, et al.Pageof 23